TY  - JOUR
AU  - Martinez-Losada, Carmen
AU  - Martin, Carmen
AU  - Gonzalez, Rafael
AU  - Manzanares, Barbara
AU  - Garcia-Torres, Estefania
AU  - Herrera, Concha
PY  - 2017
DO  - 10.3389/fimmu.2017.00810
SN  - 1664-3224
UR  - http://hdl.handle.net/10668/19501
T2  - Frontiers in immunology
AB  - Donor natural killer (NK) cells can destroy residual leukemic cells after allogeneic hematopoietic stem cell transplantation. This effect is based on the interaction of killer-cell immunoglobulin-like receptors (KIR) of donor NK cells with ligands of...
LA  - en
PB  - Frontiers Research Foundation
KW  - KIR
KW  - KIR-ligand
KW  - UCB-transplantion
KW  - Leukemia
KW  - Relapse
KW  - HLA-C antigens
KW  - Ligands
KW  - Cord blood stem cell transplantation
KW  - Fetal blood
KW  - Incidence
KW  - Receptors, KIR
KW  - Killer cells, natural
TI  - Patients Lacking a KIR-Ligand of HLA Group C1 or C2 Have a Better Outcome after Umbilical Cord Blood Transplantation.
TY  - research article
VL  - 8
ER  -